What's the Press Release based on? Any science? Like in vitro studies , mouse models? Anything at all? Or is it just in their imagination? Without any concrete scientific basis, or a web conference where analysts can question them, it's just throwing stuff up against the wall to see if it sticks -at best, or perhaps a way to juice themselves for funding given the current top of mind awareness of myelofibrosis drugs.
Frankly, this the most bizarre thing in the biotech space I have ever seen. They will laughed out by the serious scientists.
relax. I just posted the news that another company is pursuing the same space. they seem to think their compound will help out those affected by MF etc. they would not initiate a phase 2 otherwise. I just wondered what anybody thought about this